ReSurfX™ is an outcomes intelligence company 'Enabling Better Decisions and Outcomes'™ improving innovation and ROI from data intensive operations of enterprises, with primary focus on Pharma, Biotech and healthcare sectors for efficient development and delivery of patient-care. ReSurfX artificial intelligence (AI) prediction solution SyRTOP has validated support for prospective use as an ‘Advance Outcomes Alert System’™ in clinical trials and patient care. ReSurfX delivers differentiated and high value solutions through outcomes intelligence enterprise software and measurement technology redesign solutions that provide unprecedented accuracy, robustness, novel insights and predict outcomes directions in advance. ReSurfX products and functionalities leverage a novel data-source agnostic machine learning approach ‘Adaptive Hypersurface Technology™’ (AHT) we invented, to provide novel insights, advance prediction of outcomes direction and automated knowledge extraction solutions with inherent personalization. The ReSurfX::vysen™ integrative enterprise SaaS software product delivers functionalities for analytics and predictions that are proven to be the ‘best-in-class’, with sophisticated REST APIs and SDKs that are also integrated with a smooth user interface (UI). One of the predictors of ReSurfX::vysen is System Response based Triggers and Outcomes Predictor (SyRTOP™) is proven to yield unprecedented predictive ability including through a use case that predicts drug-drug interactions that lead to FDA guidance on co-prescribing drugs. The use case and other value propositions are outlined in our February 2021 post at resurfx.com/vysdom. ReSurfX team is multidisciplinary as are the products and technology and enables members to innovate, create and scale technically and market reach of our products and solutions at the leading edge. Our culture is fun loving with intensive involvement and roles are tailored to the goals and growth of team members.